Key facts
- This page summarizes Marc L. Hoffman's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Mar 2023, 18:39.
Marc L. Hoffman - 17 Mar 2023 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- RMTI
- Reported as of
- 17 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2023, 18:39:02 UTC
- Prior SEC filing
- 13 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Kull, Attorney-in-Fact for Marc L. Hoffman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Marc L. Hoffman filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 21 Mar 2023.
Change
- Previous filing in this sequence was filed on 13 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMTI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,665
- Change %
- Price
- $0.000000
- Shares after
- 25,665
- Date
- 17 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RMTI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +32,990
- Change %
- Price
- $0.000000
- Shares after
- 32,990
- Date
- 17 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,990
- Exercise price
- $1.37
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
Footnote F2
Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.